首页> 外文期刊>Journal of Medicinal Chemistry >Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives possessing reduced anticoagulant and other serine protease inhibition activities
【24h】

Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives possessing reduced anticoagulant and other serine protease inhibition activities

机译:用化学修饰的肝素和具有降低的抗凝和其他丝氨酸蛋白酶抑制活性的低分子量衍生物破坏恶性疟原虫疟疾中的玫瑰花结

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Severe malaria has been, in part, associated with the ability of parasite infected red blood cells to aggregate together with uninfected erythrocytes to form rosettes via the parasite protein PfEMP-1. In this study, inhibitors of rosetting by the Plasmodium falciparum strain R-29, based on chemically modified heparin polysaccharides (IC50 = 1.97 x 10(-2) and 3.05 x 10(-3) mg center dot mL(-1)) and their depolymerized, low molecular weight derivatives were identified with reduced anticoagulant and protease (renin, pepsin, and cathepsin-D) activities. Low molecular weight derivatives of the two most effective inhibitors were shown to have distinct minimum size and strain-specific structural requirements for rosette disruption. These also formed distinct complexes in solution when bound to platelet-factor IV.
机译:严重的疟疾在某种程度上与被寄生虫感染的红细胞与未感染的红细胞聚集在一起,通过寄生虫蛋白PfEMP-1形成玫瑰花的能力有关。在这项研究中,恶性疟原虫菌株R-29的玫瑰花结抑制剂基于化学修饰的肝素多糖(IC50 = 1.97 x 10(-2)和3.05 x 10(-3)mg中心点mL(-1))和它们的解聚低分子量衍生物具有降低的抗凝和蛋白酶(肾素,胃蛋白酶和组织蛋白酶D)活性。两种最有效的抑制剂的低分子量衍生物显示出对玫瑰花结破坏具有明显的最小尺寸和菌株特异性结构要求。当与血小板因子IV结合时,它们在溶液中也形成独特的复合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号